A Multifunctional Hybrid Nanocarrier for Non-Invasive siRNA Delivery to the Retina

Drug therapy for retinal diseases (e.g., age-related macular degeneration, the leading cause of blindness) is generally performed by invasive intravitreal injection because of poor drug delivery caused by the blood–retinal barrier (BRB). This study aimed to develop a nanocarrier for the non-invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Shogo, Takashima, Yuuki, Udagawa, Ryotaro, Ibaraki, Hisako, Seta, Yasuo, Ishihara, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962392/
https://www.ncbi.nlm.nih.gov/pubmed/36839933
http://dx.doi.org/10.3390/pharmaceutics15020611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962392/
https://www.ncbi.nlm.nih.gov/pubmed/36839933
http://dx.doi.org/10.3390/pharmaceutics15020611

Ejemplares similares